CHINA PHARMA HOLDINGS, INC. Effective Tax Rate
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Effective Tax Rate of 25.00% for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2023-11-13
- CHINA PHARMA HOLDINGS, INC. effective income tax rate reconciliation, percent for the quarter ending 2023-03-31 was 25.00%, a 0.00% change year-over-year.
- CHINA PHARMA HOLDINGS, INC. effective income tax rate reconciliation, percent for the quarter ending 2022-03-31 was 25.00%, a 0.00% change year-over-year.
- CHINA PHARMA HOLDINGS, INC. effective income tax rate reconciliation, percent for the quarter ending 2021-03-31 was 25.00%, a 0.00% change year-over-year.
- CHINA PHARMA HOLDINGS, INC. effective income tax rate reconciliation, percent for the quarter ending 2020-03-31 was 25.00%, a 0.00% change year-over-year.
- CHINA PHARMA HOLDINGS, INC. effective income tax rate reconciliation, percent for fiscal 2022 was 25.00%, a 0.00% change from fiscal 2021.
- CHINA PHARMA HOLDINGS, INC. effective income tax rate reconciliation, percent for fiscal 2021 was 25.00%, a 0.00% change from fiscal 2020.
- CHINA PHARMA HOLDINGS, INC. effective income tax rate reconciliation, percent for fiscal 2020 was 25.00%, a 0.00% change from fiscal 2019.
- CHINA PHARMA HOLDINGS, INC. effective income tax rate reconciliation, percent for fiscal 2019 was 25.00%, a 0.00% change from fiscal 2018.
| Period end | Effective Income Tax Rate Reconciliation, Percent 0 month | Effective Income Tax Rate Reconciliation, Percent 3 month | Effective Income Tax Rate Reconciliation, Percent 6 month | Effective Income Tax Rate Reconciliation, Percent 9 month | Effective Income Tax Rate Reconciliation, Percent 12 month |
|---|---|---|---|---|---|
| 2023-09-30 | 25.00% 10-Q · filed 2023-11-13 | ||||
| 2023-06-30 | 25.00% 10-Q · filed 2023-08-14 | ||||
| 2023-03-31 | 25.00% 10-Q · filed 2023-05-12 | ||||
| 2022-12-31 | 25.00% 10-K · filed 2023-03-30 | ||||
| 2022-09-30 | 25.00% 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | 25.00% 10-Q · filed 2022-08-11 | ||||
| 2022-03-31 | 25.00% 10-Q · filed 2022-05-12 | ||||
| 2021-12-31 | 25.00% 10-K · filed 2022-03-30 | ||||
| 2021-09-30 | 25.00% 10-Q · filed 2021-11-12 | ||||
| 2021-06-30 | 25.00% 10-Q · filed 2021-08-13 | ||||
| 2021-03-31 | 25.00% 10-Q · filed 2021-05-14 | ||||
| 2020-12-31 | 25.00% 10-K · filed 2021-03-26 | ||||
| 2020-09-30 | 25.00% 10-Q · filed 2020-11-13 | ||||
| 2020-06-30 | 25.00% 10-Q · filed 2020-08-13 | ||||
| 2020-03-31 | 25.00% 10-Q · filed 2020-05-14 | ||||
| 2019-12-31 | 25.00% 10-K · filed 2020-03-30 | ||||
| 2019-09-30 | 25.00% 10-Q · filed 2019-11-14 | ||||
| 2019-06-30 | 25.00% 10-Q · filed 2019-08-14 | ||||
| 2019-03-31 | 25.00% 10-Q · filed 2019-05-14 | ||||
| 2018-12-31 | 25.00% 10-K · filed 2019-03-28 | ||||
| 2018-09-30 | 25.00% 10-Q · filed 2018-11-14 | ||||
| 2018-06-30 | 25.00% 10-Q · filed 2018-08-14 | ||||
| 2018-03-31 | 25.00% 10-Q · filed 2018-05-14 | ||||
| 2017-06-30 | 15.00% 10-Q · filed 2017-08-14 | ||||
| 2007-03-16 | 25.00% 10-Q · filed 2017-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |